HOME > 홍보/투자정보 > 산업동향
바이오USA, '유전자 치료제' 공들이는 美..."4년내 40개 승인"
ViroMed
2018/06/11
www.sedaily.com/NewsView/1S0R7NRMN8

http://www.sedaily.com/NewsView/1S0R7NRMN8